Form 4: Alkermes Director Nancy Lurker Reports Stock Option and Restricted Stock Unit Award

Director Nancy Lurker reports the acquisition of stock options and restricted stock units in Alkermes plc.

Summary

• On May 31, 2024, Nancy Lurker, a director of Alkermes plc, was granted a restricted stock unit award for 8,013 ordinary shares, which will vest on May 31, 2025.
• Lurker also received a non-qualified stock option to purchase 17,492 ordinary shares at a price of $23.40, which will vest and become exercisable on May 31, 2025, and expire on May 31, 2034.
• Following these transactions, Lurker directly owns 8,013 restricted stock units and 17,492 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, aligning director interests with shareholder value. The grants themselves are not indicative of any immediate financial distress or extraordinary event.

Positives

• The granting of stock options and restricted stock units to a director aligns their interests with those of the shareholders.
• The vesting schedules encourage long-term commitment from the director.

Industry Context

Stock option and restricted stock unit grants are common practices in the pharmaceutical industry to incentivize and retain key personnel, aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the pharmaceutical industry, often benchmarked against peer companies to ensure competitiveness.
• Companies like Biogen, Amgen, and Vertex Pharmaceuticals also utilize stock options and restricted stock units as part of their executive compensation plans.
• The vesting schedules are typical, usually ranging from one to four years to encourage long-term commitment.

Stakeholder Impact

• The granting of equity to a director can align their interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
• Employees may view this as a positive sign, indicating confidence in the company's future.

Key Dates